Institutional & Family Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Institutional & Family Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2	Closed	-$228	–	769
2022 Q4	$228	Hold	2	–	–	﹤0.01%	693
2022 Q3	$0	Sell	2 -8	-80%	-$559	﹤0.01%	804
2022 Q2	$1K	Hold	10	–	–	﹤0.01%	714
2022 Q1	$1K	Buy	10 +1	+11%	+$97	﹤0.01%	756
2021 Q4	$1K	Sell	9 -6	-40%	-$655	﹤0.01%	786
2021 Q3	$2K	Sell	15 -11	-42%	-$1.14K	﹤0.01%	804
2021 Q2	$2K	Buy	26 +8	+44%	+$736	﹤0.01%	859
2021 Q1	$2K	Sell	18 -10	-36%	-$844	﹤0.01%	832
2020 Q4	$2K	Sell	28 -244	-90%	-$18.1K	﹤0.01%	814
2020 Q3	$21K	Buy	272 +220	+423%	+$15.1K	﹤0.01%	397
2020 Q2	$3K	Sell	52 -16	-24%	-$685	﹤0.01%	668
2020 Q1	$2K	Hold	68	–	–	﹤0.01%	693
2019 Q4	$2K	Hold	68	–	–	﹤0.01%	783
2019 Q3	$2K	Sell	68 -1	-1%	-$26	﹤0.01%	754
2019 Q2	$2K	Hold	69	–	–	﹤0.01%	770
2019 Q1	$2K	Hold	69	–	–	﹤0.01%	758
2018 Q4	$1K	Hold	69	–	–	﹤0.01%	816
2018 Q3	$1K	Buy	+69	New	+$1.31K	﹤0.01%	839

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Institutional & Family Asset Management's HZNP Position: Q1 2023 in Review

Institutional & Family Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 2 shares — an estimated $228 sold.

Institutional & Family Asset Management first reported a position in HZNP in Q3 2018 and held it in 18 quarters. The position peaked at $21K in Q3 2020. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

Institutional & Family Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Institutional & Family Asset Management sold 2 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $228.
Institutional & Family Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2018 and held it in 18 quarters.
Institutional & Family Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $21K in Q3 2020.
553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Institutional & Family Asset Management's 13F filing for Q1 2023, filed 9 May 2023.